MTOR and acute myeloid leukemia: Recently, mTOR inhibitors (a group of immunosuppressive agents) such as rapamycin and everolimus have been proved to be effective for AML patients by inhibiting vascular epithelial proliferation and reducing the tumor size.[39] Moreover, this therapy can also reduce the risk of rupture and bleeding.[40]